R. Villacorta

ORCID: 0000-0001-7432-6116
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Psoriasis: Treatment and Pathogenesis
  • Pharmaceutical studies and practices
  • Spondyloarthritis Studies and Treatments
  • Pharmaceutical Economics and Policy
  • Glioma Diagnosis and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Eosinophilic Esophagitis
  • Pediatric health and respiratory diseases
  • Biosimilars and Bioanalytical Methods
  • Medical Coding and Health Information
  • Respiratory viral infections research
  • Health and Lifestyle Studies
  • Dermatology and Skin Diseases
  • Mental Health Research Topics
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Meta-analysis and systematic reviews
  • Hidradenitis Suppurativa and Treatments
  • Advanced Radiotherapy Techniques
  • Influenza Virus Research Studies
  • Emergency and Acute Care Studies
  • Computational Drug Discovery Methods
  • Health, psychology, and well-being
  • Vaccine Coverage and Hesitancy

Antenor Orrego Private University
2024

Janssen (United States)
2018-2021

Janssen Scientific Affairs (United States)
2018

Highmark Blue Cross Blue Shield
2016

University of Southern California
2012-2014

LAC+USC Medical Center
2011

Total work productivity loss (WPL) and associated indirect costs contribute to the economic burden of psoriasis.To estimate total WPL related costs, identify predictors with psoriasis severity in France, Germany, Spain, U.K. Italy (EU5) U.S.A.Data from 2015 Adelphi Real World Psoriasis Disease Specific Programme, analysed for absenteeism, presenteeism WPL, were quantified (0-100%) participants who completed Work Productivity Activity Impairment (WPAI) instrument. These measures converted...

10.1111/bjd.18798 article EN cc-by-nc British Journal of Dermatology 2019-12-16

The objective of this work was to determine the cost-effectiveness temozolomide compared with that radiotherapy alone in adjuvant treatment newly diagnosed glioblastoma. Temozolomide is only chemotherapeutic agent have demonstrated a significant survival benefit randomized clinical trial. Our analysis builds on earlier by incorporating caregiver time costs and generic availability. It also first applicable US context.A systematic literature review conducted collect relevant data. Transition...

10.1093/neuonc/not096 article EN Neuro-Oncology 2013-08-09

To compare work absenteeism and short-term disability among adults with psoriasis or psoriatic arthritis (PsA), versus controls in the USA.Adults eligible for and/or benefits between 1/1/2009 4/30/2020 were screened IBM® MarketScan® Commercial Health Productivity Management Databases. The following groups defined: (1) psoriasis: ≥ 2 diagnoses 30 days apart no PsA diagnoses; (2) PsA: apart; (3) control: absence of diagnoses. Controls matched to patients based on age, gender, index year,...

10.1007/s10067-021-05839-9 article EN cc-by Clinical Rheumatology 2021-07-21

Introduction: Hypertriglyceridemia has been linked to insulin resistance. Objectives: To evaluate the relationship and predictive capacity of hypertriglyceridemia for resistance in obese children. Methods: A cross-sectional analytical study was conducted children aged 6 14 years, treated at Belén Hospital Trujillo between 2014 2019. Fifty-eight randomly selected medical records were analyzed. Insulin measured using Homeostasis Model Assessment (HOMA) index (≥3). Descriptive, correlational...

10.25176/rfmh.v24i2.6053 article EN cc-by Revista de la Facultad de Medicina Humana 2024-04-29

10.1016/j.jval.2014.03.1634 article EN publisher-specific-oa Value in Health 2014-05-01
Coming Soon ...